Voyager Therapeutics
Price & Volume
Stats
See more52W Range | $2.65-$5.96 |
Market Cap | $223.5M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $31.3M |
Revenue Growth (YoY) | -45.7% |
Gross Profit (12 Mos) | -$102.9M |
Diluted EPS | -$2.17 |
News
See moreYahoo Finance • 2 months ago
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
Yahoo Finance • 2 months ago
Voyager Reports Third Quarter 2025 Financial and Operating Results
Yahoo Finance • 3 months ago
Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders
Yahoo Finance • 4 months ago
Voyager to Present at Upcoming Investor Conferences
About
CEO | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. |
CFO | Dr. Nathan D. Jorgensen M.B.A., Ph.D. |
Address | 75 Hayden Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 172 |
